Find latest Prostate Cancer videos · 300+ videos
Insights from 2023 ESMO Annual Meeting
S

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzalutamide/Placebo + Leuprolide Acetate and Enzalutamide Monotherapy in High-Risk Biochemically Recurrent Prostate Cancer"

By Insights from 2023 ESMO Annual Meeting FEATURING Stephen Freedland
By Insights from 2023 ESMO Annual Meeting FEATURING Stephen Freedland
513 views
October 25, 2023

Disclaimer: This video was recorded prior to FDA approval of enzalutamide on November 17, 2023 for the treatment of patients with nonmetastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastasis.

Comments 0
Login to view comments. Click here to Login

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Related Videos

11:54

Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

1.0K views
15:32

Prostate Cancer Ablation - The Best Option For Your Intermediate Ris…

Preston Sprenkle

541 views
11:36

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

492 views
07:26

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

558 views
19:29

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

678 views
10:14

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

391 views
10:11

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

387 views
21:43

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

565 views
24:34

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

360 views
39:11

Advanced Prostate Cancer Therapy: Effective and Minimally Invasive

DrTalks

M. Hong

224 views
08:54

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

394 views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.2K views
08:54

Advances in Prostate Cancer Surgery

Penn Medicine Abramson Cancer Center

B. Schurhamer, T. Guzzo

272 views
35:32

Erectile Dysfunction in Patients with Prostate Cancer and Metabolic …

DrTalks

R. Valenzuela

163 views
17:55

Update on Systemic Treatments for Metastatic Prostate Cancer

Emmanuel Seront

277 views
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views
15:45

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

314 views
07:05

Avoiding Unnecessary Operations in Prostate Cancer

Penn Medicine Abramson Cancer Center

P. Pierorazio

222 views
14:16

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

2.7K views
10:56

Urologic Oncology: What to Look for in 2025

GWU Urology

254 views
AUTOPLAY